drugset / Trial / NCT05475886
6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the ED50 and ED90 for an effective 6% Hydroxyethyl starch (130/0.4) coload infusion dose for postspinal anesthesia hypotension in patients undergoing cesarean section.
Timeline
- Start
- 2024-02-01
- Primary completion
- 2024-04-21
- Completion
- 2024-04-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Volulyte | Other / unclassified | 500 ml | Other |
Indications
No indication recorded.